{
  "ptid_time": "127_S_1032_2006-11-08",
  "img_path": "/data/qiuhui/data/adni/images/127_S_1032/2006-11-08/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 5,823 mm³, 16.4% below the reference mean. With a Z-score of -1.42 (7.8th percentile), this represents mild atrophy; whole brain volume measures 899,759 mm³, 12.6% below the reference mean. With a Z-score of -1.65 (5.0th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,921 mm³, 1.2% below the reference mean. With a Z-score of -0.08 (46.8th percentile), this represents normal volume ; fusiform gyrus volume measures 13,486 mm³, 25.4% below the reference mean. With a Z-score of -2.20 (1.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 19,051 mm³, 5.6% below the reference mean. With a Z-score of -0.50 (30.9th percentile), this represents normal volume . ",
  "text_data": "Age is 84.7 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Malignancy; Major Surgical Procedures. MMSE: 27.0. Logical Memory: 6.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild hippocampal atrophy and significant fusiform gyrus atrophy, which are common in Alzheimer's disease (AD), alongside moderate whole-brain atrophy. However, the MMSE score of 27 is within the normal range, and entorhinal cortex and middle temporal gyrus volumes are preserved. The presence of one APOE4 allele increases AD risk, but cognitive performance remains intact.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (given structural changes without significant cognitive decline).  \n**Confidence:** **Medium** (due to conflicting biomarkers—some atrophy but normal MMSE).  \n\n*Note: Follow-up cognitive testing (e.g., episodic memory assessments) and CSF/pet biomarkers (e.g., amyloid/tau) would strengthen confidence.*",
  "timestamp": "2025-07-26T13:05:31.584865"
}